NCT06744387

Brief Summary

The goal of this observational study is to conduct postoperative monitoring in patients who have undergone upper or lower limb reconstructive surgery with an anterolateral thigh flap, by employing the gold standard approach: intermittent assessment of clinical parameters (flap's color, temperature, skin turgor and capillary refill time) combined with Doppler techniques, alongside continuous tissue oxygenation measurements obtained using the CASMED FORE-SIGHT ELITE monitor.The main objective of the study is to provide preliminary data on potential cut-off values indicative of flap failure.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
8mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Mar 2025Dec 2026

First Submitted

Initial submission to the registry

November 27, 2024

Completed
23 days until next milestone

First Posted

Study publicly available on registry

December 20, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

March 3, 2025

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

March 5, 2025

Status Verified

March 1, 2025

Enrollment Period

1.7 years

First QC Date

November 27, 2024

Last Update Submit

March 4, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • provide preliminary data on potential cut-off values for tissue oxygenation indicative for flap failure

    a decrease of x percent in tissue oxygenation below the baseline value (first measurement upon arrival at the PACU) of the anterolateral thigh flap.

    from end of surgery untill five days after surgery

  • provide preliminary data on potential cut-off values for tissue oxygenation indicative for flap failure

    a decrease of x percent in tissue oxygenation in the anterolateral thigh flap compared to the reference measurements obtained from the unaffected remaining anterolateral thigh.

    from end of surgery untill five days after surgery

Secondary Outcomes (1)

  • retrospective time-to-event analysis in patients with flap failure

    through study completion, an average of 1 year

Study Arms (1)

patients with reconstructive flap surgery on upper or lower limb using a fasciocutanous tigh flap

Diagnostic Test: clinical assessments and tissue oxygenation monitoring by Near Infrared Spectroscopy

Interventions

Flap failure will be identified, based upon gold standard monitoring (flaps skin color, temperature, tissue turgor and capillary refill time) along with Doppler technique during a postoperative period of five days. In all patients Near Infrared Spectroscopy (NIRS) by FORE-SIGHT ELITE will be applied to obtain continuous tissue oxygenation measurements. NIRS values and trends from patients with flap failure (case group) will be compared to NIRS values and trends from patients with no flap failure(control group).

patients with reconstructive flap surgery on upper or lower limb using a fasciocutanous tigh flap

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

scheduled for reconstructive flap surgery on either upper or lower limb using a fasciocutaneous anterolateral thigh flap

You may qualify if:

  • scheduled for reconstructive flap surgery on either upper or lower limb using a fasciocutaneous anterolateral thigh flap

You may not qualify if:

  • refusal to provide written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antwerp University Hospital

Edegem, Antwerp, 2650, Belgium

RECRUITING

Central Study Contacts

Vera Saldien, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

November 27, 2024

First Posted

December 20, 2024

Study Start

March 3, 2025

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

March 5, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations